Article: KV Pharmaceutical Acquires Exclusive Worldwide Rights to Pharmaceutical Grade Ester-C(R) Mineral Ascorbate.

Article: Zila's Inter-Cal Research Supports Advantages Of Ester-C(R) ...
PR Newswire;  March 1, 1999 ;     700+ words ... ... the advantages of Ester-C(R) mineral ascorbate, a patented form of vitamin C ... human subjects who took Ester-C mineral ascorbate maintained significantly higher levels ... levels in white cells. Ester-C mineral ascorbate, plain ascorbic acid or placebo ...

Article: NEW ESTER-C BEVERAGE GRADE MINERAL ASCORBATE ...
Health Products Business;  July 1, 2000 ;     426 words ...Prescott, AZ-based Inter-Cal Corporation has announced the development of its new Ester-C Beverage Grade mineral ascorbate. According to Inter-Cal VP/GM Michelle Michels, "Our exciting new product is currently being manufactured in ...

Article: INTER-CAL NUTRACEUTICALS.(files for patent for Ester-C ...
Chemical Market Reporter;  May 14, 2001 ;     499 words ... ... INTER-CAL NUTRACEUTICALS, a division of Zila Inc., has filed for an international patent covering thc use of Ester-C mineral ascorbate to treat cancer in humans based on preliminary independent research. The company is exploring potential partnerships with ...

Article: Zila's Inter-Cal Corporation Develops New Ester-C(R) Beverage ...
PR Newswire;  June 16, 2000 ;     700+ words ... ... and technologies for the global nutritional industry, announced the development of new Ester-C(R) Beverage Grade mineral ascorbate. Inter-Cal Vice President and General Manager Michelle Michels said, "Our exciting new product is currently being ...

Article: Zila's Inter-Cal Unit Announces New Pharmaceutical Grade Ester-C ...
PR Newswire;  December 2, 1999 ;     700+ words ... ... Ester-C(R) mineral ascorbate product. The ... agreement giving KV Pharmaceutical Company (NYSE ... grade Ester-C mineral ascorbate in both prescription ... counter products. KV Pharmaceutical is a leading ... Ester-C mineral ascorbate is non-erosive ... of exposure. ...

Article: KV Pharmaceutical Company, Purdue Pharma L.P. ...
Biotech Week;  June 24, 2009 ;     700+ words ...KV Pharmaceutical Company (NYSE: KVa; KVb) of ... of the settlement agreement, KV Pharmaceutical Company acknowledges that Purdue ... In exchange, Purdue will grant KV Pharmaceutical Company certain limited non ...

Article: KV Pharmaceutical Forms Licensing Partnership with ...
PR Newswire;  June 18, 2009 ;     700+ words ... ... 18 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company today announced that it has ... including the European Union. KV Pharmaceutical will receive undisclosed milestones ... David Van Vliet, interim CEO at KV Pharmaceutical Company said, "KV Pharmaceutical ...